Financial reports
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
13 Aug 21
10-Q
2021 Q1
Quarterly report
7 May 21
10-K
2020 FY
Annual report
18 Mar 21
40-F
2019 FY
Annual report (Canada)
10 Mar 20
20-F
2018 FY
Annual report (foreign)
11 Mar 19
40-F/A
2017 FY
Annual report (Canada) (amended)
4 Apr 18
40-F/A
2017 FY
Annual report (Canada) (amended)
13 Mar 18
40-F
2017 FY
Annual report (Canada)
9 Mar 18
20-F
2016 FY
Annual report (foreign)
10 Mar 17
Current reports
8-K
Pfizer Completes Acquisition of Trillium Therapeutics
17 Nov 21
8-K
Other Events
16 Nov 21
8-K
Trillium Therapeutics Receives Final Court Order Approving Arrangement
29 Oct 21
8-K
Trillium Securityholders Approve Acquisition by Pfizer
27 Oct 21
8-K
Other Events
20 Oct 21
8-K
Other Events
15 Oct 21
8-K
Other Events
13 Oct 21
8-K
Voting Support Agreement
23 Aug 21
8-K
Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial Results
13 Aug 21
8-K
Trillium Therapeutics Appoints Catherine Mackey, PH.D., to Its Board of Directors
30 Jun 21
Registration and prospectus
15-12B
Securities registration termination
29 Nov 21
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Nov 21
POSASR
Automatic shelf registration (post-effective amendment)
17 Nov 21
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Nov 21
POS AM
Prospectus update (post-effective amendment)
17 Nov 21
POS AM
Prospectus update (post-effective amendment)
17 Nov 21
25-NSE
Exchange delisting
17 Nov 21
S-3ASR
Automatic shelf registration
18 Mar 21
S-8
Registration of securities for employees
10 Dec 20
424B5
Prospectus supplement for primary offering
11 Sep 20
Proxies
DEFA14A
Additional proxy soliciting materials
20 Oct 21
DEFA14A
Additional proxy soliciting materials
15 Oct 21
DEFA14A
Additional proxy soliciting materials
13 Oct 21
DEFA14A
Additional proxy soliciting materials
27 Sep 21
DEFM14A
Proxy related to merger
27 Sep 21
PREM14A
Preliminary proxy related to merger
13 Sep 21
DEFA14A
Additional proxy soliciting materials
23 Aug 21
DEFA14A
Additional proxy soliciting materials
23 Aug 21
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEF 14A
Definitive proxy
30 Apr 21
Other
EFFECT
Notice of effectiveness
22 Nov 21
EFFECT
Notice of effectiveness
22 Nov 21
UPLOAD
Letter from SEC
6 May 20
EFFECT
Notice of effectiveness
5 May 20
CORRESP
Correspondence with SEC
30 Apr 20
EFFECT
Notice of effectiveness
1 Jun 18
CORRESP
Correspondence with SEC
29 May 18
UPLOAD
Letter from SEC
24 May 18
EFFECT
Notice of effectiveness
8 Jan 18
EFFECT
Notice of effectiveness
5 Jun 15